The Development of COVID-19 Vaccines – Safeguards Needed

August 4, 2020, Vol 324, No. 5, Pages 419-524

The Development of COVID-19 Vaccines – Safeguards Needed
Nicole Lurie, MD, MSPH; Joshua M. Sharfstein, MD; Jesse L. Goodman, MD, MPH


free access has multimedia has audio
JAMA. 2020;324(5):439-440. doi:10.1001/jama.2020.12461
This Viewpoint lists 4 safeguards policy makers should consider before release of a COVID-19 vaccine, including ensuring effectiveness through clinical trials, providing evidence of safety, requiring informed consent before vaccination, and establishing comprehensive adverse effects monitoring systems.
:: Audio Highlights
free access online only has audio